Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

73.05 -1.41 (-1.89%)
Streaming Delayed Price Updated: 11:46 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
31 32 Next >
3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for... 
Via The Motley Fool
Looking Into DexCom's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today
Via Benzinga
DexCom's Options Frenzy: What You Need to Know
Via Benzinga
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations
DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
NASDAQ:DXCM is showing decent growth, but is still valued reasonably.
NASDAQ:DXCM is not too expensive for the growth it is showing. 
Via Chartmill
3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the... 
Via The Motley Fool
Pet Parents Keep Spending
We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care. 
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today
Via Benzinga
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
From DexCom, Inc.
Via Business Wire
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Market Whales and Their Recent Bets on DXCM Options
Via Benzinga
DexCom Stock Earns Healthy Relative Strength Rating Upgrade
In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday. 
Via Investor's Business Daily
Analyst Expectations for DexCom's Future
Via Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer, as well as an industry leader that could... 
Via The Motley Fool
Investing $5,000 in These 3 Stocks Could Make You Rich
Artificial intelligence should be a huge tailwind for all three of these stocks. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is NASDAQ:DXCM a Fit for Growth Investing Strategies?
Is DEXCOM INC (NASDAQ:DXCM) suited for growth investing? 
Via Chartmill
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
Via Benzinga
Looking Into DexCom's Recent Short Interest
Via Benzinga
Is DexCom the Next Big Growth Stock?
It has significant growth drivers in play, but competitors are making inroads too. 
Via The Motley Fool
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
3 Growth Stocks to Buy With $1,000 Right Now
If you're having trouble finding your portfolio's next growth holding, here are three great options to choose from -- or you can choose all three. 
Via The Motley Fool
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
New medicines for weight loss and diabetes stand to disrupt the competitive scene. 
Via The Motley Fool
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry-leading stocks that billionaire investors can't stop buying. 
Via The Motley Fool
2 Stock Split Growth Stocks to Buy and Hold
These companies could continue delivering excellent results long after their most recent stock splits are forgotten. 
Via The Motley Fool
Investing Lesson: Value Drivers
Trends come, trends go. So, how can investors spot the difference between another passing fad and something with real, sustainable value? 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.